BBNX · Beta Bionics Inc. Common Stock
View on chartInsiders & Stakes
| Wellington Hadley Harbor Aggregator IV, L.P. | ▲ Buy | Open Market | 3,901,599 Shares held | 1/31/2025 | View profile |
| Sean Saint President & CEO | ▼ Sell | Open Market | 398,429 Shares held | 9/3/2026 | View profile |
| Mike Mensinger Chief Product Officer | ▼ Sell | Open Market | 177,390 Shares held | 9/16/2026 | View profile |
| Steven Jon Russell Chief Medical Officer | ▼ Sell | Open Market | 169,628 Shares held | 9/2/2026 | View profile |
| Stephen Feider Chief Financial Officer | ▼ Sell | Open Market | 159,378 Shares held | 9/2/2026 | View profile |
| Mark Hopman Chief Commercial Officer | ▼ Sell | Open Market | 56,109 Shares held | 10/1/2026 | View profile |
| Gerard J. Michel See Remarks | ▲ Buy | Grant | 33,509 Shares held | 5/21/2026 | View profile |
| Danny L. Dearen Director | ▲ Buy | Grant | 32,209 Shares held | 5/21/2026 | View profile |
| Sean Carney | ▲ Buy | Grant | 32,209 Shares held | 5/21/2026 | View profile |
| Maria Palasis | ▲ Buy | Grant | 29,397 Shares held | 5/21/2026 | View profile |
| Adam Lezack | ▼ Sell | Open Market | 27,399 Shares held | 5/22/2026 | View profile |
| Christy Jones | ▼ Sell | Open Market | 19,564 Shares held | 9/22/2026 | View profile |
Transaction History
| Mark Hopman | ▼ Sell | Open Market | 370 | $7K | 10/1/2026 |
| Christy Jones | ▼ Sell | Open Market | 6,430 | $148K | 9/22/2026 |
| Mark Hopman | ▼ Sell | Open Market | 30,779 | $620K | 9/16/2026 |
| Mike Mensinger | ▼ Sell | Open Market | 2,650 | $58K | 9/16/2026 |
| Mark Hopman | ▼ Sell | Open Market | 775 | $12K | 9/14/2026 |
| Mark Hopman | ▼ Sell | Open Market | 36,870 | $681K | 9/9/2026 |
| Sean Saint | ▼ Sell | Open Market | 5,641 | $113K | 9/3/2026 |
| Mike Mensinger | ▼ Sell | Open Market | 4,375 | $84K | 9/2/2026 |
| Stephen Feider | ▼ Sell | Open Market | 6,675 | $128K | 9/2/2026 |
| Sean Saint | ▼ Sell | Open Market | 16,867 | $322K | 9/2/2026 |
| Mark Hopman | ▼ Sell | Open Market | 5,327 | $102K | 9/2/2026 |
| Steven Jon Russell | ▼ Sell | Open Market | 4,221 | $81K | 9/2/2026 |
| Stephen Feider | ▲ Buy | Option Exercise | 4,896 | $25K | 6/29/2026 |
| Stephen Feider | ▼ Sell | Open Market | 4,896 | $83K | 6/29/2026 |
| Stephen Feider | ▲ Buy | Option Exercise | 4,982 | $25K | 6/26/2026 |
| Stephen Feider | ▼ Sell | Open Market | 5,104 | $87K | 6/26/2026 |
| Mark Hopman | ▼ Sell | Open Market | 1,258 | $19K | 6/24/2026 |
| Christy Jones | ▼ Sell | Open Market | 1,406 | $21K | 6/24/2026 |
| Mark Hopman | ▼ Sell | Open Market | 275 | $3K | 6/4/2026 |
| Christy Jones | ▼ Sell | Open Market | 2,811 | $39K | 6/4/2026 |
| Steven Jon Russell | ▼ Sell | Open Market | 4,222 | $53K | 6/2/2026 |
| Stephen Feider | ▼ Sell | Open Market | 6,676 | $84K | 6/2/2026 |
| Sean Saint | ▼ Sell | Open Market | 16,872 | $213K | 6/2/2026 |
| Mark Hopman | ▼ Sell | Open Market | 5,329 | $67K | 6/2/2026 |
| Mike Mensinger | ▼ Sell | Open Market | 4,378 | $55K | 6/2/2026 |
| Adam Lezack | ▼ Sell | Open Market | 998 | $11K | 5/22/2026 |
| Sean Carney | ▲ Buy | Grant | 16,965 | $0 | 5/21/2026 |
| Adam Lezack | ▼ Sell | Open Market | 1,000 | $10K | 5/21/2026 |
| Adam Lezack | ▲ Buy | Grant | 16,965 | $0 | 5/21/2026 |
| Gerard J. Michel | ▲ Buy | Grant | 16,965 | $0 | 5/21/2026 |
| Christy Jones | ▼ Sell | Open Market | 1,998 | $20K | 5/21/2026 |
| Christy Jones | ▲ Buy | Grant | 16,965 | $0 | 5/21/2026 |
| Maria Palasis | ▲ Buy | Grant | 16,965 | $0 | 5/21/2026 |
| Danny L. Dearen | ▲ Buy | Grant | 16,965 | $0 | 5/21/2026 |
| Mark Hopman | ▼ Sell | Open Market | 353 | $4K | 3/4/2026 |
| Mark Hopman | ▼ Sell | Open Market | 834 | $10K | 3/2/2026 |
| Steven Jon Russell | ▼ Sell | Open Market | 1,026 | $13K | 3/2/2026 |
| Mike Mensinger | ▼ Sell | Open Market | 1,064 | $13K | 3/2/2026 |
| Stephen Feider | ▼ Sell | Open Market | 1,428 | $18K | 3/2/2026 |
| Sean Saint | ▼ Sell | Open Market | 3,384 | $42K | 3/2/2026 |
| Mark Hopman | ▲ Buy | Grant | 109,105 | $0 | 2/27/2026 |
| Steven Jon Russell | ▲ Buy | Grant | 109,105 | $0 | 2/27/2026 |
| Mike Mensinger | ▲ Buy | Grant | 109,105 | $0 | 2/27/2026 |
| Stephen Feider | ▲ Buy | Grant | 131,543 | $0 | 2/27/2026 |
| Sean Saint | ▲ Buy | Grant | 343,269 | $0 | 2/27/2026 |
| Danny L. Dearen | ▲ Buy | Grant | 3,997 | $0 | 1/13/2026 |
| Gerard J. Michel | ▲ Buy | Grant | 3,997 | $0 | 1/13/2026 |
| Sean Carney | ▲ Buy | Grant | 3,997 | $0 | 1/13/2026 |
| Maria Palasis | ▲ Buy | Grant | 3,997 | $0 | 1/13/2026 |
| Christy Jones | ▲ Buy | Grant | 3,997 | $0 | 1/13/2026 |
| Adam Lezack | ▲ Buy | Grant | 3,997 | $0 | 1/13/2026 |
| Mike Mensinger | ▼ Sell | Open Market | 2,200 | $66K | 1/6/2026 |
| Stephen Feider | ▼ Sell | Open Market | 20,000 | $591K | 1/2/2026 |
| Mike Mensinger | ▼ Sell | Open Market | 7,200 | $213K | 1/2/2026 |
| Mike Mensinger | ▼ Sell | Open Market | 600 | $18K | 1/2/2026 |
| Stephen Feider | ▲ Buy | Option Exercise | 20,000 | $102K | 1/2/2026 |
| Mark Hopman | ▼ Sell | Open Market | 2,061 | $63K | 12/4/2025 |
| Sean Saint | ▼ Sell | Open Market | 3,278 | $96K | 12/2/2025 |
| Mark Hopman | ▼ Sell | Open Market | 856 | $25K | 12/2/2025 |
| Steven Jon Russell | ▼ Sell | Open Market | 1,025 | $30K | 12/2/2025 |
| Mike Mensinger | ▼ Sell | Open Market | 1,063 | $31K | 12/2/2025 |
| Stephen Feider | ▼ Sell | Open Market | 1,427 | $42K | 12/2/2025 |
| Adam Lezack | ▼ Sell | Open Market | 906 | $27K | 12/1/2025 |
| Adam Lezack | ▼ Sell | Open Market | 500 | $15K | 12/1/2025 |
| Maria Palasis | ▼ Sell | Open Market | 906 | $27K | 12/1/2025 |
| Maria Palasis | ▼ Sell | Open Market | 500 | $15K | 12/1/2025 |
| Adam Lezack | ▼ Sell | Open Market | 1,368 | $37K | 10/31/2025 |
| Adam Lezack | ▼ Sell | Open Market | 38 | $1K | 10/31/2025 |
| Maria Palasis | ▼ Sell | Open Market | 1,287 | $35K | 10/31/2025 |
| Maria Palasis | ▼ Sell | Open Market | 119 | $3K | 10/31/2025 |
| Stephen Feider | ▲ Buy | Option Exercise | 4,982 | $25K | 10/3/2025 |
| Stephen Feider | ▼ Sell | Open Market | 3,828 | $82K | 10/3/2025 |
| Stephen Feider | ▼ Sell | Open Market | 1,154 | $26K | 10/3/2025 |
| Stephen Feider | ▲ Buy | Option Exercise | 15,018 | $77K | 10/1/2025 |
| Stephen Feider | ▼ Sell | Open Market | 14,918 | $310K | 10/1/2025 |
| Stephen Feider | ▼ Sell | Open Market | 100 | $2K | 10/1/2025 |
| Stephen Feider | ▲ Buy | Option Exercise | 9,900 | $50K | 9/8/2025 |
| Stephen Feider | ▼ Sell | Open Market | 9,900 | $209K | 9/8/2025 |
| Mark Hopman | ▲ Buy | Option Exercise | 11,411 | $58K | 9/5/2025 |
| Mark Hopman | ▼ Sell | Open Market | 11,411 | $235K | 9/5/2025 |
| Stephen Feider | ▲ Buy | Option Exercise | 100 | $510 | 9/5/2025 |
| Stephen Feider | ▼ Sell | Open Market | 100 | $2K | 9/5/2025 |
| Mark Hopman | ▲ Buy | Option Exercise | 656 | $3K | 9/4/2025 |
| Mark Hopman | ▲ Buy | Option Exercise | 4,093 | $21K | 9/4/2025 |
| Mark Hopman | ▼ Sell | Open Market | 6,818 | $136K | 9/4/2025 |
| Sean Saint | ▼ Sell | Open Market | 3,359 | $63K | 9/2/2025 |
| Steven Jon Russell | ▼ Sell | Open Market | 1,015 | $19K | 9/2/2025 |
| Mike Mensinger | ▼ Sell | Open Market | 1,089 | $21K | 9/2/2025 |
| Mark Hopman | ▼ Sell | Open Market | 848 | $16K | 9/2/2025 |
| Stephen Feider | ▼ Sell | Open Market | 1,462 | $28K | 9/2/2025 |
| Stephen Feider | ▲ Buy | Option Exercise | 4,413 | $23K | 8/22/2025 |
| Stephen Feider | ▼ Sell | Open Market | 4,413 | $75K | 8/22/2025 |
| Mark Hopman | ▲ Buy | Option Exercise | 16,158 | $82K | 8/19/2025 |
| Mark Hopman | ▼ Sell | Open Market | 16,158 | $268K | 8/19/2025 |
| Stephen Feider | ▲ Buy | Option Exercise | 5,587 | $28K | 8/19/2025 |
| Stephen Feider | ▼ Sell | Open Market | 5,587 | $95K | 8/19/2025 |
| Mark Hopman | ▼ Sell | Open Market | 238 | $4K | 6/2/2025 |
| Mark Hopman | ▼ Sell | Open Market | 551 | $10K | 6/2/2025 |
| Mark Hopman | ▼ Sell | Open Market | 79 | $1K | 6/2/2025 |
| Steven Jon Russell | ▼ Sell | Open Market | 285 | $5K | 6/2/2025 |
| Steven Jon Russell | ▼ Sell | Open Market | 660 | $12K | 6/2/2025 |
| Steven Jon Russell | ▼ Sell | Open Market | 94 | $2K | 6/2/2025 |
| Mike Mensinger | ▼ Sell | Open Market | 306 | $5K | 6/2/2025 |
| Mike Mensinger | ▼ Sell | Open Market | 708 | $13K | 6/2/2025 |
| Mike Mensinger | ▼ Sell | Open Market | 101 | $2K | 6/2/2025 |
| Stephen Feider | ▼ Sell | Open Market | 410 | $7K | 6/2/2025 |
| Stephen Feider | ▼ Sell | Open Market | 951 | $17K | 6/2/2025 |
| Stephen Feider | ▼ Sell | Open Market | 136 | $3K | 6/2/2025 |
| Sean Saint | ▼ Sell | Open Market | 943 | $16K | 6/2/2025 |
| Sean Saint | ▼ Sell | Open Market | 2,185 | $40K | 6/2/2025 |
| Sean Saint | ▼ Sell | Open Market | 311 | $6K | 6/2/2025 |
| Gerard J. Michel | ▲ Buy | Grant | 12,547 | $0 | 3/26/2025 |
| Christy Jones | ▲ Buy | Grant | 11,247 | $0 | 3/15/2025 |
| Maria Palasis | ▲ Buy | Grant | 11,247 | $0 | 3/15/2025 |
| Danny L. Dearen | ▲ Buy | Grant | 11,247 | $0 | 3/15/2025 |
| Adam Lezack | ▲ Buy | Grant | 11,247 | $0 | 3/15/2025 |
| Sean Carney | ▲ Buy | Grant | 11,247 | $0 | 3/15/2025 |
| Mark Hopman | ▲ Buy | Grant | 35,000 | $0 | 2/27/2025 |
| Steven Jon Russell | ▲ Buy | Grant | 35,000 | $0 | 2/27/2025 |
| Mike Mensinger | ▲ Buy | Grant | 35,000 | $0 | 2/27/2025 |
| Stephen Feider | ▲ Buy | Grant | 47,000 | $0 | 2/27/2025 |
| Sean Saint | ▲ Buy | Grant | 108,000 | $0 | 2/27/2025 |
| Mike Mensinger | ▼ Sell | Other | 10,575 | $212 | 1/31/2025 |
| Mike Mensinger | ▼ Sell | Open Market | 13 | $221 | 1/31/2025 |
| Mike Mensinger | ▲ Buy | Open Market | 33,350 | $567K | 1/31/2025 |
| Wellington Hadley Harbor Aggregator IV, L.P. | ▼ Sell | Other | 2,901,599 | — | 1/31/2025 |
| Wellington Hadley Harbor Aggregator IV, L.P. | ▲ Buy | Open Market | 1,000,000 | $17.0M | 1/31/2025 |
| Mike Mensinger | ▼ Sell | Other | 15,107 | — | 1/31/2025 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Beta Bionics Signs Senseonics Deal, Gets New Analyst Coverage
Beta Bionics announced an agreement to integrate its iLet Bionic Pancreas with Senseonics' Eversense 365 sensor. This partnership aims to create a more comprehensive automated insulin delivery system. Additionally, Wells Fargo initiated coverage with an Overweight rating and a $28 price target, while Truist raised its target to the same level. The stock is currently trading within its 52-week range, with an average analyst target of $22.40.
Beta Bionics Signs Senseonics Deal, Gets New Analyst Coverage. Beta Bionics announced an agreement to integrate its iLet Bionic Pancreas with Senseonics' Eversense 365 sensor. This partnership aims to create a more comprehensive automated insulin delivery system. Additionally, Wells Fargo initiated coverage with an Overweight rating and a $28 price target, while Truist raised its target to the same level. The stock is currently trading within its 52-week range, with an average analyst target of $22.40.